Alzheimer Continuing Education

Alzheimer’s disease (AD), a heterogeneous, neurodegenerative condition with an insidious onset and slow progression, is the leading cause of disability and morbidity as well as the sixth-leading cause of death in the United States. Diagnosing AD is often challenging, and multimodal imaging strategies and other novel and emerging biomarkers can aid in differential diagnosis. Currently only symptomatic therapies are available, but recent clinical trials investigating disease-modifying therapies (DMTs) that could slow or reverse the progression of AD have shown great promise.
CME Outfitters is pleased to offer accredited CME/CE activities providing expert-led education on the pathogenesis of AD, current diagnostic criteria and guidelines for AD management, recent advances in the development of AD biomarkers, and the latest clinical evidence on emerging therapies.

Jump to:


Live & On-Demand Webcasts CMEOCast Videos and Interactive 3D Models


Patient Resources Clinical Practice Guidelines

Looking Ahead: Integrating Emerging Therapies and Tools in Early-Stage Alzheimer's Disease


Participate Now  

This Live and OnDemand webcast will feature interactive and lively discussion among specialists who treat patients with AD, with a focus on recognizing early-stage symptoms of AD, the potential role of emerging therapies in treating patients with early-stage AD, and integrating multimodal imaging strategies into the diagnostic process.

How to Use Digital Cognitive Testing Tools to Aid in the Diagnosis of Mild Cognitive Impairment (MCI) and Dementia


Participate Now  

This CME Outfitters podcast focuses on integrating cognitive testing into annual wellness visits for adults in order to identify cognitive impairment early to initiate referral to a specialist, and on integrating digital cognitive assessments into clinical workflow and remotely to differentiate normal aging from preclinical cognitive decline.

Videos and Interactive 3D Models

Pathophysiology of Alzheimer's Disease

In this video, Dr. Sharon Cohen discusses the formation of amyloid-ß aggregates and intracellular neurofibrillary tau tangles that are characteristic of Alzheimer’s Disease.

Emerging Therapies for Alzheimer's Disease

In this video, Dr. Sharon Cohen reviews monoclonal antibodies targeting amyloid-ß, including aducanumab, BAN-2401, solanezumab, and gantenerumab.

Interactive 3D Model of Alzheimer's Disease Pathophysiology and Emerging Treatments

Open the model in a new window

  • Use the navigation buttons in the lower-right corner of the animated 3D model to move between the 2 chapters and to play or pause the animation sequences.
  • To zoom, rotate, or pan, use the CONTROLS MENU or click MORE OPTIONS > Help > 3D Navigation Basics for tips on navigating with your mouse, keyboard, or touchscreen.
  • For a tutorial, click the icon for MORE OPTIONS and then select Help from the popup menu.
  • To add your own drawings or notes and download your customized images, click MORE OPTIONS and then Open Whiteboard.

Patient Resources